TY  - JOUR

T1  - EGFR-Targeted and MMP-Activated Membranolytic Peptides Kill Cancer Cells Specifically In Vitro and Reduce Tumor Growth In Vivo

JO  - Molecular Pharmaceutics

UR  - https://doi.org/10.1021/acs.molpharmaceut.5c01774

PY  - 2026/04/01

AU  - Pramanik A

AU  - Booth A

AU  - Kobza D

AU  - Brackenbury WJ

AU  - Connell SD

AU  - Beales PA

AU  - Hughes TA

ED  - 

DO  - DOI: 10.1021/acs.molpharmaceut.5c01774

PB  - American Chemical Society (ACS)

Y2  - 2026/04/27

ER  -